Proteomic Biomarker Analytics Global Market Report 2022: Proteomics Set to Overtake Genomics as New Frontier in Biotechnology - ResearchAndMarkets.com

Proteomic Biomarker Analytics is just finding its feet, but the opportunity is to understand the front line players, the actual proteins and protein complexes, that do the work of managing cellular life. Players are reporting double digit growth. Venture capital is well involved.

This technology could possibly displace most cancer diagnostic protocols and save money at the same time. The report forecasts the market size out for five years for a number of different market segments.

This research makes you the expert in your organization. Get the publisher's research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. As always, assistance, and additional specific data, is provided without additional charges.

Key Topics Covered:

1 Market Guides

1.1 Situation Analysis

1.2 Guide for Executives and Marketing Staff

1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

2.1 What is Proteomic Biomarker Analytics?

2.2 Proteomics and Drug Development

2.3 Market Definition

2.3.1 Market Size

2.3.2 Currency

2.3.3 Years

2.4 Methodology

2.4.1 Methodology

2.4.2 Sources

2.4.3 Authors

3 Proteomic Biomarker Analytics - Guide to Technologies

3.1 Methods

3.1.1 Separation Techniques and Electrophoresis

3.1.2 Mass Spectrometry

3.1.3 Chromatography

3.1.4 Blotting

3.1.5 Protein Complementation Assays and Interaction Screens

3.1.6 Protein Structure Prediction

3.1.7 Protein Databases

4 Industry Overview

4.1 Players in a Dynamic Market

4.1.1 Academic Research Lab

4.1.2 Diagnostic Test Developer

4.1.3 Genomic Instrumentation Supplier

4.1.3.1 Cell Separation and Viewing Instrumentation Supplier

4.1.4 Pharmaceutical/Reagent Supplier

4.1.5 Independent Testing Lab

4.1.6 Public National/Regional Lab

4.1.7 Hospital Lab

4.1.8 Physician Lab

4.1.9 Audit Body

4.1.10 Certification Body

5 Market Trends

5.1 Factors Driving Growth

5.1.1 Drug Development

5.1.2 Companion Dx

5.1.3 Fertile Research

5.1.4 Technology Convergence

5.2 Factors Limiting Growth

5.2.1 the Cost Curve

5.2.2 Capacity Constraints

5.2.3 Market Lag

6 Proteomic Analytics Recent Developments

6.1 Recent Developments - Importance and How to Use this Section

6.1.1 Importance of These Developments

6.1.2 How to Use this Section

6.2 Deepmind AI Predicts 3D Structure of Every Protein

6.3 Quanterix Slashing Workforce by 25 Percent

6.4 Study Shows Potential of Nanomosaic's Platform for Biomarker Development

6.5 Exact Sciences Bolsters Plasma Proteomics Tech With $15M Purchase of Omicera

6.6 Prognomiq Exploring Multiomic Markers for Variety of Cancer Dx Applications

6.7 Octave Bioscience Building Evidence Base for Multiple Sclerosis Test

6.8 Proteomics Goes Public

7 Profiles of Key Proteomic Biomarker Analytic Companies

8 Global Proteomic Analytics Markets

9 Global Protein Analytics Markets - by Application

9.1 Protein Analytics Drug Discovery

9.2 Protein Analytics Research Application

9.3 Protein Analytics Clinical Dx

9.4 Protein Analytics Other Applications

10 Global Protein Analytics Markets - by Technology

10.1 Protein Analytics Mass Spectrometry

10.2 Protein Analytics Elisa/Beads

10.3 Protein Analytics Hybrid Multiplex

10.4 Protein Analytics Other Technology

11 Global Protein Analytics Markets - by Product

11.1 Protein Analytics Instruments

11.2 Protein Analytics Kits & Reagents

11.3 Protein Analytics Services

12 Global Protein Analytics Markets - by Place

12.1 Protein Analytics Academic

12.2 Protein Analytics Pharma/Biotech

12.3 Protein Analytics Clinical

12.4 Protein Analytics Other Place

13 Appendices

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/l003bj

View source version on businesswire.com:https://www.businesswire.com/news/home/20221111005206/en/

    CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

             For GMT Office Hours Call +353-1-416-8900

KEYWORD:
    

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
    

SOURCE: Research and Markets

Copyright Business Wire 2022.

PUB: 11/11/2022 05:56 AM/DISC: 11/11/2022 05:56 AM

http://www.businesswire.com/news/home/20221111005206/en